Lv1
1 积分 2021-10-06 加入
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
7小时前
待确认
Clinical trials in systemic lupus erythematosus: the dilemma—Why have phase III trials failed to confirm the promising results of phase II trials?
9小时前
已完结
Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
4天前
已完结
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver
8天前
已完结
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
9天前
已完结
Establishment and characterization of a mouse model for studying kidney repair in diabetes
11天前
已关闭
Inflammation-Responsive Polyion Complex Vesicles for Autoimmune Disease Therapy via Cell-Free DNA Scavenging and Inflammatory Microenvironment Modulation
11天前
已完结
Circulating cathepsin S improves glycaemic control in mice
20天前
已关闭
Acute kidney injury
23天前
已完结
An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis
26天前
已完结
皖公网安备34019202002308
